|Articles|October 3, 2008

Merz USA names new president and CEO

Greensboro, N.C. - Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com.

Greensboro, N.C.

- Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to

dbusinessnews.com

.

Mr. Britts will oversee the medical dermatology business, as well as establish two new product avenues in aesthetics and neurology.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME